Publikationen AG Myokardiale Inflammation

Publikationsverzeichnis

Originalarbeiten:

Torzewski J, Li K, Zimmermann O. Road map to drug discovery and development – Inhibiting C-reactive protein for the treatment of cardiovascular disease. J Bioequiv Availab 2011 S1 Review

Zimmermann O, Sharma S, Paiphansiri U, Mailänder V, Rottbauer W, Landfester K, Rasche V. MRI contrast agent-loaded polymeric nanocapsules as versatile vehicle for targeted imaging. Hospital Imaging and Radiology Europe (HIRE) 2010

Sharma S, Paiphansiri U, Hombach V, Mailänder V, Zimmermann O, Landfester K, Rasche V. Characterization of MRI contrast agent-loaded polymeric nanocapsules as versatile vehicle for targeted imaging. Contrast Media Mol Imaging 2010 5:59-69

Zimmermann O, Rodewald C, Radermacher M, Vetter M, Wiehe JM, Bienek-Ziolkowski M, Hombach V, Torzewski J. Interferon -1b therapy in chronic viral dilated cardiomyopathy - is there a role for specific therapy? J Card Fail 2010 16:348-356

Zimmermann O, Bienek-Ziolkowski M, Wolf B, Vetter M, Baur R, Mailänder V, Hombach V, Torzewski J. Myocardial inflammation and non-ischaemic heart failure: is there a role for C-reactive protein? Basic Res Cardiol 2009 104:591-599

Hombach V, Merkle N, Torzewski J, Kraus JM, Kunze M, Zimmermann O, Kestler HA, Wöhrle J. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2009 30:2011-2018

Wiehe JM, Ponsaerts P, Rojewski MT, Homann JM, Greiner J, Kronawitter D, Schrezenmeier H, Hombach V, Wiesneth M, Zimmermann O, Torzewski J. mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression. J Cell Mol Med 2007 11:521-530

Zimmermann O, Kochs M, Zwaka TP, Bienek-Ziolkowski M, Hoher M, Hombach V, Torzewski J. Prognosic role of myocardial tumor necrosis factor-alpha and terminal complement complex expression in patients with dilated cardiomyopathy. Eur J Heart Fail 2007 9:51-54

Wiehe JM, Niesler C, Torzewski J, Zimmermann O, Wiesneth M, Schmitt M, Schwarz K, Döhner H, Hombach V, Greiner J. Efficient transient genetic labeling of human CD34+ progenitor cells for in vivo application. Regen Med 2006 2:223-234  

Zimmermann O, Grebe O, Merkle N, Hombach V, Torzewski J. Author reply to letter from J Smedema. Eur J Heart Fail 2006 8:330

Zimmermann O, Zwaka TP, Marx N, Torzewski M, Bucher A, Guilliard P, Hannekum A, Hombach V, Torzewski J. Serum starvation and growth factor receptor expression in vascular smooth muscle cells. J Vasc Res 2006 43:157-165

Zimmermann O, Grebe O, Merkle N, Nusser T, Kochs M, Bienek-Ziolkowski M, Hombach V, Torzewski J. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail 2006 8:162-166

Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, Hoher M, Hombach V, Torzewski J. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol 2005 104:92-100

Wiehe JM, Zimmermann O, Greiner J, Homann JM, Wiesneth M, Hombach V, Torzewski J. Labeling of adult stem cells for in vivo-application in the human heart. Histol Histopathol 2005 20:901-906


CME-Fortbildungsbeiträge:

Waßmuth R, Schulz-Menger J, Torzewski J, Zimmermann O, Hombach V. Magnetresonanztomographie, Myokardbiopsie und inflammatorische Kardio-myopathie. Kardiologie up2date 2006 9:289-299


Kasuistiken:

Haerter G, Zimmermann O, Maier L, Schubert A, Mertens T, Kern P, Woehrle J. Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus. Clin Infect Dis 2010 50:1249-1251

gepunktete blaue Linie 1000px breit